Parallel Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$0.28 - $1.16 $1,076 - $4,461
-3,846 Reduced 33.28%
7,710 $2,000
Q1 2024

May 06, 2024
BUY
$1.06 - $1.67 $434 - $684
410 Added 3.68%
11,556 $13,000
Q4 2023

Feb 09, 2024
SELL
$1.26 - $1.79 $1,668 - $2,369
-1,324 Reduced 10.62%
11,146 $18,000
Q3 2023

May 20, 2024
BUY
$1.61 - $2.54 $167 - $264
104 Added 0.84%
12,470 $22,000
Q3 2023

Nov 13, 2023
BUY
$1.61 - $2.54 $167 - $264
104 Added 0.84%
12,470 $22,000
Q2 2023

May 20, 2024
BUY
$1.14 - $1.95 $5,013 - $8,576
4,398 Added 55.2%
12,366 $23,000
Q2 2023

Aug 04, 2023
BUY
$1.14 - $1.95 $5,013 - $8,576
4,398 Added 55.2%
12,366 $23,000
Q1 2023

May 20, 2024
SELL
$1.2 - $2.19 $4,305 - $7,857
-3,588 Reduced 31.05%
7,968 $10,000
Q1 2023

Apr 25, 2023
SELL
$1.2 - $2.19 $2,958 - $5,398
-2,465 Reduced 23.63%
7,968 $10,000
Q4 2022

Feb 03, 2023
BUY
$1.63 - $3.52 $3,858 - $8,331
2,367 Added 29.35%
10,433 $17,000
Q3 2022

Nov 10, 2022
BUY
$0.73 - $3.74 $926 - $4,746
1,269 Added 18.67%
8,066 $25,000
Q2 2022

Aug 01, 2022
BUY
$2.2 - $4.2 $14,953 - $28,547
6,797 New
6,797 $16,000
Q4 2021

Jan 20, 2022
SELL
$8.31 - $14.92 $20,775 - $37,300
-2,500 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$9.15 - $13.28 $22,875 - $33,200
2,500 New
2,500 $29,000

Others Institutions Holding DNA

# of Institutions
43
Shares Held
48.4M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email